Literature DB >> 464594

Pharmacokinetics of intravenous amoxicillin in pediatric patients.

R C Rudoy, N Goto, D Pettit, H Uemura.   

Abstract

Pharmacokinetic parameters were obtained from 14 infants and children receiving intravenous amoxicillin. Peak serum values increased proportionally to the increase in dose; the serum half-life was similar in the three dose groups studied.

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 464594      PMCID： PMC352722          DOI： 10.1128/AAC.15.4.628

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


  5 in total

1.  Pharmacokinetics of amoxicillin.

Authors:  D Zarowny; R Ogilvie; D Tamblyn; C MacLeod; J Ruedy
Journal:  Clin Pharmacol Ther       Date:  1974-12       Impact factor: 6.875

2.  Pharmacokinetics of amoxicillin: dose dependence after intravenous, oral, and intramuscular administration.

Authors:  D A Spyker; R J Rugloski; R L Vann; W M O'Brien
Journal:  Antimicrob Agents Chemother       Date:  1977-01       Impact factor: 5.191

3.  Amoxycillin: a new semi-synthetic penicillin.

Authors:  R Sutherland; E A Croydon; G N Rolinson
Journal:  Br Med J       Date:  1972-07-01

4.  Microbioassay of antimicrobial agents.

Authors:  H J Simon; E J Yin
Journal:  Appl Microbiol       Date:  1970-04

5.  Amoxicillin, a new penicillin antibiotic.

Authors:  H H Handsfield; H Clark; J F Wallace; K K Holmes; M Turck
Journal:  Antimicrob Agents Chemother       Date:  1973-02       Impact factor: 5.191
  5 in total
  5 in total

1.  Single-dose pharmacokinetics of intravenous clavulanic acid with amoxicillin in pediatric patients.

Authors:  U B Schaad; P A Casey; D L Cooper
Journal:  Antimicrob Agents Chemother       Date:  1983-02       Impact factor: 5.191

2.  Scaling beta-lactam antimicrobial pharmacokinetics from early life to old age.

Authors:  Dagan O Lonsdale; Emma H Baker; Karin Kipper; Charlotte Barker; Barbara Philips; Andrew Rhodes; Mike Sharland; Joseph F Standing
Journal:  Br J Clin Pharmacol       Date:  2018-11-26       Impact factor: 4.335

3.  Dose Rationale for Amoxicillin in Neonatal Sepsis When Referral Is Not Possible.

Authors:  Salvatore D'Agate; Flora Tshinanu Musuamba; Oscar Della Pasqua
Journal:  Front Pharmacol       Date:  2020-09-25       Impact factor: 5.810

Review 4.  Amoxycillin injectable: a review of its antibacterial spectrum, pharmacokinetics and therapeutic use.

Authors:  R N Brogden; R C Heel; T M Speight; G S Avery
Journal:  Drugs       Date:  1979-09       Impact factor: 9.546

5.  Amoxicillin pharmacokinetics in preterm infants with gestational ages of less than 32 weeks.

Authors:  J J Huisman-de Boer; J N van den Anker; M Vogel; W H Goessens; R C Schoemaker; R de Groot
Journal:  Antimicrob Agents Chemother       Date:  1995-02       Impact factor: 5.191
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.